Evaluation of Virtual Care in Kidney Transplant Recipients in the Early Posttransplant Period

This is the authors' abstract. We don't add key points for this paper.

Background Though virtual care was widely adopted during the COVID‐19 pandemic, evidence to support its use in kidney transplant recipients early after transplantation is limited. Methods We conducted a retrospective cohort study comparing post kidney transplant outcomes in patients who received in‐person transplant care before the COVID‐19 pandemic with those who received mainly virtual transplant care during the COVID‐19 pandemic. The usual‐care group included 69 patients who received a kidney transplant from March 1, 2019 to September 1, 2019, and the virtual‐care group included 64 patients who received a kidney transplant from September 1, 2020 to March 1, 2021. Results At 6 months, five patients in the usual‐care group and three patients in the virtual‐care group died. There was one graft loss and one episode of acute rejection in the usual‐care group, and two episodes of acute rejection in the virtual‐care group ( p = 0.60). Estimated glomerular filtration rate was higher for patients in the virtual‐care group (59 mL/min/1.73 m 2 vs. 52 mL/min/1.73 m 2 , p = 0.046) and serum creatinine was not different (138 µmol/L vs. 127 µmol/L, p = 0.27). There was no difference in mean blood pressure or hospitalizations. Conclusion Outcomes were similar among recipients of a kidney transplant prior to the COVID‐19 pandemic when care was mainly in person and during the pandemic when care was mainly virtual, without a signal of harm. Patient and donor selection may have led to unmeasured differences between groups.